The Firm is representing Pamplona Capital Management in connection with its acquisition of MedAssets (NASDAQ: MDAS) for $31.35 per share, which represents a total enterprise value of approximately $2.7 billion. The transaction, which is expected to close in the first quarter of 2016, is subject to shareholder and regulatory approval and other customary closing conditions.
In connection with the transaction, Pamplona also agreed to divest MedAssets’ Spend and Clinical Resource Management segment to VHA-UHC Alliance NewCo, Inc., the nation’s largest member-owned health care company. Following completion of its acquisition of MedAssets, Pamplona intends to combine MedAssets’ Revenue Cycle Management segment with Precyse Solutions, Inc., a Pamplona-owned company which provides performance management and technology, focused on health information management (HIM) performance solutions.
Pamplona Capital Management is a London- and New York-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. MedAssets is a healthcare performance improvement company that combines strategic market insight with rapid operational execution to help providers sustainably serve the needs of their communities.
The Simpson Thacher team includes Matthew Gabbard, Michael Guo, Jivaji More, Kirsten Popoff, Sung Jin and Ariana Evarts (M&A); Brian Steinhardt, Brian Gluck, Jennifer Albrecht and Leah Nudelman (Credit); Ryan Bekkerus (Capital Markets); Philip Mirrer-Singer and Kolya Glick (Antitrust); Larry Moss, Andrew Blau and Eric Wolf (Executive Compensation and Employee Benefits); Devin Heckman and John Torrenti (Tax); Noah Leibowitz, Genevieve Dorment and Veronica Jordan-Davis (IP); Krista McManus (Real Estate); Abram Ellis (Regulatory); and Adeeb Fadil and Louise Kruger (Environmental).